Primary Breast Diffuse Large B Cell Lymphoma: Summarization of 12 Cases / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 452-456, 2016.
Artigo
em Chinês
| WPRIM
| ID: wpr-360068
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the clinicopathological manifestation, immunophenotypic features and prognostic factors of patients with primary breast DLBCL (PB-DLBCL).</p><p><b>METHODS</b>Twelve cases of PB-DLBCL, diagnosed according to the 2008 World Health Organization classification of tumors of hematopoietic and lymphoid tissues, were retrospectively studied.</p><p><b>RESULTS</b>Most patients were admitted to hospital because of painless unilateral breast mass. Out of 12 cases, 5 were in Ann Arbor stage I (41.7%), 7 case were in stage II (58.3%). Most (89.9%) were assigned to non-GCB subtypes, 11.1% were classified as GCB subtype. The patients who recepted treatment were sensitive to chemotherapy and they were all alive following 12 to 92 months.</p><p><b>CONCLUSION</b>Primary breast DLBCL is extremely rare without specific clinical features. They all respond well to chemotherapy and show good prognosis.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patologia
/
Prognóstico
/
Terapêutica
/
Neoplasias da Mama
/
Taxa de Sobrevida
/
Estudos Retrospectivos
/
Linfoma Difuso de Grandes Células B
/
Diagnóstico
/
Estadiamento de Neoplasias
Tipo de estudo:
Estudo diagnóstico
/
Estudo observacional
/
Estudo prognóstico
Limite:
Humanos
Idioma:
Chinês
Revista:
Journal of Experimental Hematology
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS